Depletion of FAM60A impairs the activities of Akt and β‐catenin, weakens the development of pancreatic cancer cells after xenotransplantation, and increases the sensitivity of pancreatic cancer cells to gemcitabine; thus, it may be a new therapeutic target for pancreatic cancer.35 This evidence concerns the gene AKT1 and pancreatic neoplasm.